Drug profile · INN
brimonidine
ALPHAGAN
brimonidine (ALPHAGAN) is a adrenergic receptor alpha-2 agonist. Associated with AbbVie.
Drug details — brimonidine
- Class
- Dermatologicals (D11)
- Route
- —
- Patents
- 3
- Programs
- 7
- Data quality
- 0.83
Quick answer
brimonidine (ALPHAGAN) is a adrenergic receptor alpha-2 agonist. Associated with AbbVie.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
EP 2079529
ANTIMIKROBIELLE ZUSAMMENSETZUNG MIT EINEM GEHALT AN BISPYRIDINIUMALKAN (OCTENIDIN-DIHYDROCHLORID)
granted -
EP 1926473
ANTIMIKROBIELLE ZUBEREITUNGEN MIT EINEM IN LIPOSOMEN VERKAPSELTEN GEHALT AN OCTENIDINDIHYDROCHLORID
granted -
WO 2007031520
UTILISATION DE DICHLORHYDRATE D'OCTENIDINE DANS DES PREPARATIONS SEMI-SOLIDES
granted
Frequently asked questions
What is brimonidine?
brimonidine (ALPHAGAN) is a adrenergic receptor alpha-2 agonist. Associated with AbbVie.
What is the brand name for brimonidine?
ALPHAGAN is a marketed brand name for brimonidine. Check FDA Drugs@FDA for the current US label holder and prescribing information.